From: Activation of miR-500a-3p/CDK6 axis suppresses aerobic glycolysis and colorectal cancer progression
Characteristics | miR-500a-3p expression | P | |
---|---|---|---|
High (n = 67) | Low (n = 67) | ||
Gender | 0.587 | ||
 Male | 42 (62.7) | 45 (67.2) |  |
 Female | 25 (37.3) | 22 (32.8) |  |
Age, year | 61.0 ± 13.0 | 63.6 ± 10.0 | 0.227 |
Location | 0.089 | ||
 Right side | 18 (26.9) | 10 (14.9) |  |
 Left side | 49 (73.1) | 57 (85.1) |  |
Tumor size | 0.022 | ||
 < 5 cm | 21 (31.3) | 34 (50.7) |  |
 ≥ 5 cm | 46 (68.7) | 33 (49.3) |  |
Differentiation | 0.043 | ||
 Well/moderately | 46 (68.7) | 56 (83.6) |  |
 Poor | 21 (31.3) | 11 (16.4) |  |
Depth of tumor | 0.259 | ||
 T1–T3 | 58 (86.6) | 62 (92.5) |  |
 T4 | 9 (13.4) | 5 (7.5) |  |
Lymph node | 0.119 | ||
 Positive | 31 (46.3) | 40 (59.7) |  |
 Negative | 36 (53.7) | 27 (40.3) |  |
Distant metastasis | 0.825 | ||
 Yes | 55 (82.1) | 54 (80.6) |  |
 No | 12 (17.9) | 13 (19.4) |  |
TNM stage | 0.226 | ||
 I–II | 28 (41.8) | 35 (52.2) |  |
 III–IV | 39 (58.2) | 32 (47.8) |  |